Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1.

Human vaccines & immunotherapeutics - 1 Jan 2014

Pontillo Alessandra, Da Silva Ronaldo C, Moura Ronald, Crovella Sergio

Abstract excerpt

Host genome is still poorly investigated in the context of vaccine or immunotherapy, however recently findings emphasized that it may affect the response to those treatments. In our retrospective study we evaluated the effect of HIV-1 genetic restriction factors on the response to dendritic cell (DC)-based immunotherapy in a Brazilian cohort of HIV positive (HIV+) patients that underwent a phase I clinical trial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brazil
Share to Carrier Proteins
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to HIV Infections

Share to Immunotherapy

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24240316
DOI: 10.4161/hv.27125
PMCID: PMC4185894

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1.PMID 24240316Read ↗

Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.Semantic proximity Read ↗

Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy.Semantic proximity Read ↗

Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.Semantic proximity Read ↗

CUL5 and APOBEC3G Polymorphisms are Partially Implicated in HIV-1 Infection and Antiretroviral Therapy in a Brazilian Population.Semantic proximity Read ↗

Considering genetic profiles in functional studies of immune responsiveness to HIV-1.Semantic proximity Read ↗

Genome-wide association study implicates PARD3B-based AIDS restriction.Semantic proximity Read ↗

The association of CD209 promoter variants with tuberculosis infection susceptibility, AIDS development, and treatment response outcomes among an HIV-1 Moroccan populationSemantic proximity Read ↗

Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians.Semantic proximity Read ↗

Genetic determinants of HIV‐1 infection and progression to AIDS: immune response genesSemantic proximity Read ↗

Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection.Semantic proximity Read ↗

Impact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort.Semantic proximity Read ↗

Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.